| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e44b13bf7cfacc0a1781e254345dee0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5474fbe2c22b56e29aa1a0e0b050d32f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75f372badf8b7b611727f4aafbf3bd3e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7805d471cea50578e1ce9d9a6dac7543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f235977ee6c80aefa681ea2b78cf0a06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5973f312f1e4699519d19ab60ef55ac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6e88859652c8dc003239faf4b3ff0e7 |
| publicationDate |
2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2021121564-A1 |
| titleOfInvention |
Combining adenovirus and checkpoint inhibitors for treating cancer |
| abstract |
The invention relates to the combination therapy comprising oncolytic adenovirus vector and a checkpoint inhibitor or checkpoint inhibitors. More specifically, the invention relates to oncolytic adenovirus vector and checkpoint inhibitor or checkpoint inhibitors for use in a cancer therapy. |
| priorityDate |
2016-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |